| [1] |
Kansen HM, Le TM, Uiterwaal C,et al. Prevalence and predictors of uncontrolled asthma in children referred for asthma and other atopic diseases[J]. J Asthma Allergy, 2020,13:67-75. doi: 10.2147/JAA.S231907.
|
| [2] |
Li H, Li X. Genetic relationships between high blood eosinophil count, asthma susceptibility,and asthma severity[J]. J Asthma, 2024,61:119-131.doi: 10.1080/02770903.2023.2247490.
|
| [3] |
Liao X, Gao S, Xie F,et al. An underlying mechanism behind interventional pulmonology techniques for refractory asthma treatment: neuro-immunity crosstalk[J]. Heliyon, 2023,9:e20797. doi: 10.1016/j.heliyon.2023.e20797.
|
| [4] |
Lian Z, Qi H, Liu X,et al. Ambient ozone, and urban PM2.5 co-exposure, aggravate allergic asthma via transi-ent receptor potential vanilloid 1-mediated neurogenic inflammation[J]. Ecotoxicol Environ Saf, 2022,243:114000.doi:10.1016/j.ecoenv.2022.114000.
|
| [5] |
Foisset F, Lehalle C, Nasri A,et al. Production of innervated bronchial epithelium from a blood sample[J]. Rev Mal Respir, 2023,40:247-249. doi:10.1016/j.rmr.2023.01.021.
|
| [6] |
Balestrini A, Joseph V, Dourado M,et al. A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment[J]. J Exp Med, 2021,218. doi:10.1084/jem.20201637.
|
| [7] |
Rouadi PW, Idriss SA, Bousquet J,et al. WAO-ARIA consensus on chronic cough-part Ⅱ: phenotypes and mechanisms of abnormal cough presentation-updates in COVID-19[J]. World Allergy Organ, 2021,14:100618. doi:10.1016/j.waojou.2021.100618.
|
| [8] |
Nayak AP, Lim JM, Arbel E,et al.Cooperativity between β-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation[J]. FASEB J, 2021,35:e21674. doi: 10.1096/fj.202100154R.
|
| [9] |
Goodwin K, Jaslove JM, Tao H,et al.Patterning the embryonic pulmonary mesenchyme[J]. iScience, 2022,25:103838. doi: 10.1016/j.isci.2022.103838.
|
| [10] |
Chiba Y, Ueda C, Kohno N,et al. Attenuation of relaxing response induced by pituitary adenylate cyclase-activating polypeptide in bronchial smooth muscle of experimental asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2020,319:L786-L793. doi: 10.1152/ajplung.00315.2020.
|
| [11] |
Hanusrichterova J, Mokry J, Al-Saiedy MR,et al. Factors influencing airway smooth muscle tone: a comprehensive review with a special emphasis on pulmonary surfactant[J]. Am J Physiol Cell Physiol, 2024,327:C798-C816.doi: 10.1152/ajpcell.00337.2024.
|
| [12] |
Tsuge M, Ikeda M, Tsukahara H. Novel lung growth strategy with biological therapy targeting airway remodeling in childhood bronchial asthma[J]. Children (Basel), 2022,9:1253.doi: 10.3390/children9081253.
|
| [13] |
Kwon HJ, Hahn KR, Nam SM,et al. Purpurin amelio-rates D-galactose-induced aging phenotypes in mouse hippocampus by reducing inflammatory responses[J]. Neurochem Int,2023,167:105552.doi: 10.1016/j.neuint.2023.105552.
|
| [14] |
Cai X, Li Y, Liu Q,et al. Exploration of the shared gene signatures and molecular mechanisms between chronic bronchitis and antineutrophil cytoplasmic antibody-associated glomerulonephritis: evidence from transcriptome data[J]. Curr Pharm Des, 2024,30:1966-1984. doi: 10.2174/0113816128297623240521070426.
|
| [15] |
Gubernatorova EO, Namakanova OA, Gorshkova EA,et al. Novel anti-cytokine strategies for prevention and treatment of respiratory allergic diseases[J]. Front Immunol, 2021,12:601842.doi:10.3389/fimmu.2021.601842
|
| [16] |
Ji Y, Wang E, Mohammed MT,et al. Selective production of IL-33-neutralizing autoantibody ameliorates asthma responses and severity[J]. Clin Immunol,2024,264:110234. doi:10.1016/j.clim.2024.110234.
|
| [17] |
Meteran H, Sivapalan P, Stæhr Jensen JU. Treatment response biomarkers in asthma and COPD[J]. Diagnostics (Basel),2021,11.doi:10.3390/diagnostics11091668.
|
| [18] |
Yeo YH, Liang J, Lauzon M,et al.Immunotherapy and transarterial radioembolization combination treatment for advanced hepatocellular carcinoma[J]. Am J Gastroenterol, 2023,118:2201-2211. doi:10.14309/ajg.0000000000002467.
|
| [19] |
Zheng S, Lin Z, Zhang R,et al. Progress in immuno-therapy for brain metastatic melanoma[J]. Front Oncol, 2025,14:1485532.doi:10.3389/fonc.2024.1485532.
|
| [20] |
Gençer Tuluy M, Havlucu Y, Kizilirmak D,et al. Evaluation of the efficacy of Omalizumab as retreatment in patients with severe asthma[J]. Am J Med Sci, 2025,370:30-34. doi:10.1016/j.amjms.2025.03.012.
|
| [21] |
中国医药教育协会慢性气道疾病专业委员会, 中国哮喘联盟. 重度哮喘诊断与处理中国专家共识(2024)[J]. 中华医学杂志,2024, 104: 1759-1789. doi:10.3760/cma.j.cn112137-20231117-01120.
|
| [22] |
Alzaabi A, Idrees M, Behbehani N,et al.Patients′ and physicians′ attitudes and perception about asthma in the Gulf: a subset analysis from the Asthma Insights and Management Survey in the Gulf and Russia[J]. Allergy Asthma Proc, 2021,42:e77-e85. doi:10.2500/aap.2021.42.210027.
|
| [23] |
Paz-Velarde BA, Arellano-Arteaga KJ, Bedolla-Pulido A,et al. Prevalence of asthma in patients hospitalized for pneumonia associated to SARS-CoV-2 infection[J]. Rev Alerg Mex, 2023,70:1-7. doi:10.29262/ram.v70i1.1175.
|
| [24] |
Nagase H, Ito R, Ishii M,et al.Relationship between asthma control status and health-related quality of life in japan: a cross-sectional mixed-methods study[J]. Adv Ther, 2023,40:4857-4876. doi:10.1007/s12325-023-02660-5.
|
| [25] |
Kilic T, Kilic Aydin N, Kirici Berber N,et al. Evaluation of erectile dysfunction in patients with asthma[J]. Int J Clin Pract, 2021,75:e14300. doi:10.1111/ijcp.14300.
|
